Actuate Therapeutics Inc. Company Profile
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.679-0.0452 (-6.24%)
At close: Oct 8, 3:59 PM ET · Delayed 15 min
Actuate Therapeutics at a glance
Actuate Therapeutics Inc. (NASDAQ: ACTU) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2024. At a market capitalization of $17.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001652935, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Actuate Therapeutics Inc.
- Ticker
- NASDAQ: ACTU
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2024
- Market cap
- $17.39M
- SEC CIK
- 0001652935
Companies similar to Actuate Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NCELNewcelX Ltd. | 2.99 | -1.43% | $17.27M | vs ACTU |
| NEUPNeuphoria Therapeutics Inc. | 3.35 | -2.05% | $18.13M | vs ACTU |
| RADXRadiopharm Theranostics Limited ADR | 1.11 | -3.48% | $16.20M | vs ACTU |
| RKTORocket One Inc. | 0.6461 | -3.57% | $16.09M | vs ACTU |
| PTNPalatin Technologies Inc. | 9.01 | -5.36% | $16.05M | vs ACTU |
| LPCNLipocine Inc. | 1.93 | -12.27% | $15.91M | vs ACTU |
| ALLRAllarity Therapeutics Inc. | 0.9999 | +1.62% | $15.91M | vs ACTU |
| MRKRMarker Therapeutics Inc. | 0.95 | -8.65% | $15.84M | vs ACTU |